TY - JOUR T1 - In Vitro Glucuronidation of the Antibacterial Triclocarban and its Oxidative Metabolites JF - Drug Metabolism and Disposition JO - Drug Metab Dispos DO - 10.1124/dmd.111.042283 SP - dmd.111.042283 AU - Nils Helge Schebb AU - Bastian Franze AU - Ronald Maul AU - Anupama Ranganathan AU - Bruce D. Hammock Y1 - 2011/01/01 UR - http://dmd.aspetjournals.org/content/early/2011/09/27/dmd.111.042283.abstract N2 - Triclocarban (3,4,4'-trichlorocarbanilide, TCC) is widely used as an antibacterial in bar soaps. During usage of these soaps a significant portion of TCC is absorbed by humans. For the elimination from the body, glucuronidation plays a key role in both biliary and renal clearance. In order to investigate this metabolic pathway, we performed microsomal incubations of TCC and its hydroxylated metabolites 2'OH-TCC, 3'-OH-TCC, and 6-OH-TCC. Utilizing a new LC-UV-MS/MS method we could show a rapid glucuronidation for all OH-TCCs by the uridine-5'-diphosphate-glucuronosyltransferases (UGT) present in liver microsomes of humans (HLM), Cynomolgus-monkeys (CLM), rats (RLM), and mice (MLM). Among the tested human UGT isoforms, UGT1A7, UGT1A8 and UGT1A9 showed the highest activity for the conjugation of hydroxylated TCC metabolites followed by UGT1A1, UGT1A3 and UGT1A10. Due to this broad pattern of active UGTs, OH-TCCs can be efficiently glucuronidated in various tissues, as shown for microsomes from human kidney (HKM) and intestine (HIM). The major renal metabolites in humans, TCC-N-glucuronide and TCC-N-glucuronide, were formed at very low conversion rates (<1%) by microsomal incubations. Low amounts of N-glucuronides were generated by HLM, HIM and HKM as well as by MLM and CLM, but not by RLM, according to the observed species specificity of this metabolic pathway. Among the human UGT isoforms only UGT1A9 had activity for the N-glucuronidation of TCC. These results present an anomaly where in vivo the predominant urinary metabolites of TCC are N and N'-glucuronides, but these compounds are produced slowly in vitro. ER -